Dr PEYRON Christine

Fiche personne

Coordonnées

Pôle d'économie et de gestion
2 boulevard Gabriel
BP 26 611
21066 DIJON Cedex

03 80 39 35 29

Territoire

Bourgogne

Statut

Enseignant-Chercheur

Recherche

Expertises :
- Economie de la santé

Publications

Parental acceptability of newborn screening expansion in the genomic era: A nationwide French survey informed by the Theoretical Framework of Acceptability (SeDeN-p3).

Level C, Faivre L, Lemaitre M, Salvi D, Marchetti-Waternaux I, Cudry E, Simon E, Bourgon N, Benachi A, Van NT, Coppola C, Binquet C, Thauvin-Robinet C, Huet F, Peyron C

PLoS One. 2026 06 15;21(6):e0343754

Genomic pathway managers: a novel role in the genomic medicine care pathway in France-overview and perspectives.

Gaudillat L, Patay L, Santenard J, Baurand A, Beaudouin A, Salvi D, Level C, Faivre L, Nowak F, Peyron C, Thauvin-Robinet C

Eur J Hum Genet. 2025 12 9;:

Cardiogenetics and uncertainty: evaluation of professional vulnerability in France.

Gaudillat L, Patay L, Sawka C, Baurand A, Nambot S, Level C, Laurent G, Eicher JC, Bertaux G, Eicher SF, Denis C, Carvallo S, Cazeneuve C, Janin A, Millat G, Peyron C, Thauvin-Robinet C, Charron P, Faivre L

Eur J Med Genet. 2025 02 9;:104999

Expectations, needs and mid-term outcomes in people accessing to secondary findings from ES: 1st French mixed study (FIND Study).

Viora-Dupont E, Robert F, Chassagne A, Pélissier A, Staraci S, Sanlaville D, Edery P, Lesca G, Putoux A, Pons L, Cadenes A, Baurand A, Sawka C, Bertolone G, Spetchian M, Yousfi M, Salvi D, Gautier E, Vitobello A, Denommé-Pichon AS, Bruel AL, Tran Mau-Them F, Faudet A, Keren B, Labalme A, Chatron N, Abel C, Dupuis-Girod S, Poisson A, Buratti J, Mignot C, Afenjar A, Whalen S, Charles P, Heide S, Mouthon L, Moutton S, Sorlin A, Nambot S, Briffaut AS, Asensio ML, Philippe C, Thauvin-Robinet C, Héron D, Rossi M, Meunier-Bellard N, Gargiulo M, Peyron C, Binquet C, Faivre L

Eur J Hum Genet. 2024 05 27;:

Oral anticancer medicine interventions: A cross-sectional study in French community pharmacies.

Macé F, Peyron C, Cransac A, Pistre P, Boulin M

J Oncol Pharm Pract. 2024 03 7;:10781552241237743

[Patients treated with anticancer drugs: Practices and expectations of community pharmacists].

Macé F, Boulin M, Cransac A, Pistre P, Peyron C

Bull Cancer. 2024 02;111(2):176-189

General practitioners-community pharmacists pharmacotherapy discussion groups: Analysis of their implementation through a series of case studies.

Macé F, De Vriese C, Nelissen-Vrancken M, Ruggli M, Brülhart M, Peyron C

Explor Res Clin Soc Pharm. 2023 12;12:100331

[The possible contribution of community pharmacist upstream of drug prescription in France: An experiment of practice groups between general practitioners and community pharmacists].

Macé F, Peyron C

Ann Pharm Fr. 2023 05;81(3):538-551

Efficiency of telemedicine for acute stroke: a cost-effectiveness analysis from a French pilot study.

Wallut L, Peyron C, Hervieu-Bègue M, Osseby GV, Giroud M, Legris N, Quantin C, Béjot Y, Lejeune C

Int J Technol Assess Health Care. 2020 Mar 2;:1-7

Secondary actionable findings identified by exome sequencing: expected impact on the organisation of care from the study of 700 consecutive tests.

Thauvin-Robinet C, Thevenon J, Nambot S, Delanne J, Kuentz P, Bruel AL, Chassagne A, Cretin E, Pelissier A, Peyron C, Gautier E, Lehalle D, Jean-Marçais N, Callier P, Mosca-Boidron AL, Vitobello A, Sorlin A, Tran Mau-Them F, Philippe C, Vabres P, Demougeot L, Poé C, Jouan T, Chevarin M, Lefebvre M, Bardou M, Tisserant E, Luu M, Binquet C, Deleuze JF, Verstuyft C, Duffourd Y, Faivre L

Eur. J. Hum. Genet.. 2019 Apr 24;:

Exome sequencing in clinical settings: preferences and experiences of parents of children with rare diseases (SEQUAPRE study).

Chassagne A, Pélissier A, Houdayer F, Cretin E, Gautier E, Salvi D, Kidri S, Godard A, Thauvin-Robinet C, Masurel A, Lehalle D, Jean-Marçais N, Thevenon J, Lesca G, Putoux A, Cordier MP, Dupuis-Girod S, Till M, Duffourd Y, Rivière JB, Joly L, Juif C, Putois O, Ancet P, Lapointe AS, Morin P, Edery P, Rossi M, Sanlaville D, Béjean S, Peyron C, Faivre L

Eur. J. Hum. Genet.. 2019 Feb 1;:

Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature.

Delanne J, Nambot S, Chassagne A, Putois O, Pelissier A, Peyron C, Gautier E, Thevenon J, Cretin E, Bruel AL, Goussot V, Ghiringhelli F, Boidot R, Tran-Mau-Them F, Philippe C, Vitobello A, Demougeot L, Vernin C, Lapointe AS, Bardou M, Luu M, Binquet C, Lejeune C, Joly L, Juif C, Baurand A, Sawka C, Bertolone G, Duffourd Y, Sanlaville D, Pujol P, Geneviève D, Houdayer F, Thauvin-Robinet C, Faivre L

Eur J Med Genet. 2018 Aug 27;:

Preference heterogeneity with respect to whole genome sequencing. A discrete choice experiment among parents of children with rare genetic diseases.

Peyron C, Pélissier A, Béjean S

Soc Sci Med. 2018 Aug 21;214:125-132

[Changes in clinical practice related to the arrival of next-generation sequencing in the genetic diagnosis of developmental diseases].

Demougeot L, Houdayer F, Pélissier A, Mohrez F, Thevenon J, Duffourd Y, Nambot S, Gautier E, Binquet C, Rossi M, Sanlaville D, Béjean S, Peyron C, Thauvin-Robinet C, Faivre L

Arch Pediatr. 2018 Feb;25(2):77-83